Babar Ghias
CFO & Head of Corporate DevelopmentMr. Babar Ghias is Head of Corporate Development and Chief Financial Officer at BioCryst Pharmaceuticals, Inc. since July 7,2025. He joined AvenCell Therapeutics, Inc. in May 2022 and served as its Chief Financial Officer. He has experience in the healthcare industry, including managing financial and business operations, private investing and investment banking. He served as Chief Operating Officer of Castle Creek Biosciences, Inc and was its Chief Financial Officer, where he oversaw corporate functions and led the expansion efforts transforming the company from single disease to multi-platform company via licensing and acquisitions. He was Chief Operating Officer at Fibrocell Science Inc. since 2020. As Executive Vice President of Investments & Portfolio Management at Paragon Biosciences, a global biotech development firm, he was instrumental in founding four biotechnology companies focused on rare diseases and helping to launch their operational teams. He also served as CFO and Head of Corporate Development at Marathon Pharmaceuticals, a specialty rare disease company, where he created the company’s finance infrastructure to address its continuous growth from a clinical- to commercial-stage company and ultimately, led the successful sale of the firm. Early in his career, he was an investment banker who served as a senior member of the mergers and acquisitions team at Credit Suisse, providing strategic advice to clients and boards of directors in the healthcare and life sciences industries. He was the Chief Financial Officer of Marathon Pharmaceuticals, LLC since August 12, 2015. Mr. Ghias served as Vice President of Corporate Development at Marathon Pharmaceuticals, LLC since August 2014. Mr. Ghias is responsible for identifying and evaluating business development opportunities, deal structuring, financial strategy and managing Marathon's capital structure. He was an analyst for the Investment Banking Group at UBS Securities in Pakistan. He holds an MBA from Washington University in St. Louis and a Bachelor's of science Degree in economics from Lahore University of Management Sciences in Pakistan.
Positions
- Company NameBioCryst Pharmaceuticals, Inc.Stock CodeBCRXPositionCFO & Head of Corporate DevelopmentColleagues
- CKCharles K. GayerCEO, President & Director
- VJVincent J. MilanoIndependent Chairman
- APAlane P. BarnesSenior VP, Chief Legal Officer & Corporate Secretary
- JRJohn RueschChief Technical Operations Officer
- DWDavid W. JenkinsChief Scientific Officer
- AGAlan G. LevinIndependent Director
- SKSteven K. GalsonIndependent Director
- AMA. Machelle SandersIndependent Director
